Media
Media content pertaining to the business and technologies of Deep Genomics
Press Releases Media Events
Featured

DEEP GENOMICS SECURES $226 MILLION CAD LED BY SOFTBANK AS IT SCALES AI DRUG DISCOVERY PLATFORM
July 28, 2021

BetaKit
Read More

Deep Genomics, now flush with cash, plans to take dozens of RNA therapies to the clinic
July 30, 2021

Endpoints News
Read More

Toronto AI meets Boston biotech: Deep Genomics raises $180 million to automate drug discovery
July 28, 2021

The Boston Globe
Read More

Deep Genomics hits the partnering ground running with BioMarin deal
November 18, 2020

Amirah Al Idrus, Fierce Biotech

Read More

BioMarin taps AI upstart Deep Genomics for discovery pact; Praxis says it has a path to lifting clinical hold
November 17, 2020

Jason Mast, Amber Tong, Endpoints News

Read More

Deep Genomics nabs a CBO from Synlogic as it looks to ramp up partnering
November 5, 2020

Amirah Al Idrus, Fierce Biotech

Read More

Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
January 20, 2020

Jennifer Alsever, Fortune

Computers are sifting through an endless archive of biological data and quickly finding patterns that it would take a human a lifetime to discover.

Read More

SpaceX investor backs Toronto AI upstart's journey into the 'dark region' of genetic diseases
January 7, 2020

Amber Tong, Endpoint News

Brendan Frey set out, when he began the project to pick out a lead program for Deep Genomics, to prove that the artificial intelligence systems his lab has designed can identify new drug targets and find a winning candidate much faster than traditional methods. 

Read More

Find Us

MaRS Centre, 661 University Avenue, Suite 480
Toronto, Ontario, Canada, M5G 1M1

Follow Us

Contact Us

Megan Murphy
contact@deepgenomics.com
© 2023 DEEP GENOMICS. ALL RIGHTS RESERVED. PRIVACY POLICY